Should one use medications in combination with cognitive training? If so, which ones

Journals of Gerontology - Series B Psychological Sciences and Social Sciences

Volumn 62, Issue SPEC. ISSUE 1, 2007, Pages 11-18

  Yesavage, Jerome ^a,b,c   Hoblyn, Jennifer ^a,b   Friedman, Leah ^b   Mumenthaler, Martin ^b   Schneider, Bret ^a,b   O'Hara, Ruth ^b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; NOOTROPIC AGENT;

AGED; ATTENTION; COGNITIVE DEFECT; COGNITIVE THERAPY; DRUG EFFECT; HUMAN; MEMORY DISORDER; METHODOLOGY; MULTIMODALITY CANCER THERAPY; RECALL; REVIEW;

AGED; ATTENTION; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION DISORDERS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; HUMANS; MEMORY DISORDERS; MENTAL RECALL; NOOTROPIC AGENTS;

EID: 34548038784     PISSN: 10795014     EISSN: None     Source Type: Journal    
DOI: 10.1093/geronb/62.special_issue_1.11     Document Type: Article

References (78)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2. Arendash, G. W., Sengstock, G. J., Sanberg, P. R., & Kem, W. R. (1995). Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Research, 674, 252-259.
3. Areosa, S., & Sherriff, F. (2003). Memantine for dementia. Cochrane Database of Systematic Reviews, 3, CD003154.
4. Ball, K. K., Roenker, D. L., Wadley, V. G., Edwards, J. D., Roth, D. L., McGwin, G., et al. (2006). Can high-risk older drivers be identified through performance-based measures in a department of motor vehicles setting? Journal of the American Geriatrics Society, 54, 77-84.
5. Baranski, J. V., Pigeau, R., Dinich, P., & Jacobs, I. (2004). Effects of modafinil on cognitive and meta-cognitive performance. Human Psychopharmacology, 19, 323-332. (Pubitemid 39106873)
6. Bartus, R. T., Dean, R. L., III, Beer, B., & Lippa, A. S. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science, 217, 408-414.
7. Bowen, D. M, Smith, C. B., White, P., & Davison, A. N. (1976). Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain, 99, 459-496.
8. Brooks, J. O., III, Friedman, L., Gibson, J. M, & Yesavage, J. A. (1993). Spontaneous mnemonic strategies used by older and younger adults to remember proper names. Memory, 1, 393-407.
9. Brooks, J. O., III, Friedman, L., Pearman, A., Gray, C., & Yesavage, J. A. (1999). Mnemonic training in older adults: Effects of age, length of training, and type of cognitive pretraining. International Psychogeriatrics, 11, 75-84. (Pubitemid 29161247)
10. Brooks, J. O., III, Friedman, L., & Yesavage, J. A. (1993). A study of the problems older adults encounter when using a mnemonic technique. International Psychogeriatrics, 5, 57-65. (Pubitemid 23144205)
11. Brooks, J. O., III, Friedman, L., & Yesavage, J. A. (2003). Use of an external mnemonic to augment the efficacy of an internal mnemonic in older adults. International Psychogeriatrics, 15, 59-67. (Pubitemid 36666826)
12. Caldwell, J. A., Caldwell, J. L., Smith, J. K., & Brown, D. L. (2004). Modafinil's effects on simulator performance and mood in pilots during 37 h without sleep. Aviation, Space, and Environmental Medicine, 75, 777-784. (Pubitemid 39142074)
13. Connelly, P. J., & Prentice, N. P. (2005). Current smoking and response to cholinesterase inhibitor therapy in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 19, 11-14. (Pubitemid 39664182)
14. Crook, T., Bartus, R. T., Ferris, S. H., Whitehouse, P., Cohen, G. D., & Gershon, S. (1986). Age-associated memory impairment: Proposed diagnostic criteria and measures of clinical change. Developmental Neuropsychology, 2, 261-276.
15. Davies, P., & Maloney, A. J. (1976). Selective loss of central cholinergic neurons in Alzheimer's disease [Letter to the editor]. Lancet, 2, 1403. (Pubitemid 8004505)
16. Davis, K. L., Mohs, R. C., Tinklenberg, J. R., Pfefferbaum, A., Hollister, L. E., & Kopell, B. S. (1978). Physostigmine: Improvement of long-term memory processes in normal humans. Science, 201, 272-274. (Pubitemid 8396755)
17. Everitt, B. J., & Robbins, T. W. (1997). Central cholinergic systems and cognition. Annual Review of Psychology, 48, 649-684. (Pubitemid 127485189)
18. Ferris, S. H., & Kluger, A. (1996). Commentary on age-associated memory impairment, age-related cognitive decline and mild cognitive impairment. Aging, Neuropsychology and Cognition, 3, 148-153. (Pubitemid 26355261)
19. Francis, P. T., Palmer, A. M, Snape, M, & Wilcock, G. K. (1999). The cholinergic hypothesis of Alzheimer's disease: A review of progress. Journal of Neurology, Neurosurgery and Psychiatry, 66, 137-147. (Pubitemid 29103513)
20. Furey, M L., Pietrini, P., & Haxby, J. V. (2000). Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science, 2000, 2315-2319. (Pubitemid 32041576)
21. Furey, M L., Pietrini, P., Haxby, J. V., Alexander, G. E., Lee, H. C., & VanMeter, J. (1997). Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory. Proceedings of the National Academy of Sciences, 94, 6512-6516. (Pubitemid 27270716)
22. Gratzinger, P., Sheikh, J. I., & Yesavage, J. A. (1990). Cognitive intervention and pretraining to improve face-name recall: The role of personality trait differences. Developmental Psychology, 26, 889-893.
23. Hill, R. D., Yesavage, J. A., Sheikh, J., & Friedman, L. F. (1989). Mental status as a predictor of response to memory training in older adults. Educational Gerontology, 15, 633-639. (Pubitemid 20076248)
24. Ihl, R. (2003). The impact of drugs against dementia on cognition in aging and mild cognitive impairment. Pharmacopsychiatry, 36(Suppl. 1), S38-S43. (Pubitemid 37047007)
25. Israel, L., Melac, M, Milinkevitch, D., & Dubos, G. (1994). Drug therapy and memory training programs: A double-blind randomized trial of general practice patients with age-associated memory impairment. International Psychogeriatrics, 6, 155-170. (Pubitemid 24361660)
26. Kramer, A. F., & Willis, S. L. (2002). Enhancing the cognitive vitality of older adults. Current Directions in Psychological Science, 11, 173-176.
27. Little, J. T., Johnson, D. N., Minichiello, M, Weingartner, H., & Sunderland, T. (1998). Combined nicotinic and muscarinic blockade in elderly normal volunteers: Cognitive, behavioral, and physiologic responses. Neuropsychopharmacology, 19, 60-69. (Pubitemid 28255214)
28. McGeer, E., & McGeer, P. L. (1976). Age changes in the human for some enzymes associated with metabolism of catecholamines, GABA, and acetylcholine. In J. M Ordee & R. R. Brizee (Eds.), Neurobiology of aging (pp. 287-305). New York: Raven Press.
29. McKhann, G., Drachman, D., Folstein, M, Katzman, R., Price, D., & Stadlan, E. M (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939-944. (Pubitemid 14076461)
30. McKitrick, L. A., Friedman, L. F., Brooks, J. O., Pearman, A., Kraemer, H. C., & Yesavage, J. A. (1999). Predicting response of older adults to mnemonic training: Who will benefit? International Psychogeriatrics, 11, 289-300. (Pubitemid 29466173)
31. Miguel-Hidalgo, J., Alvarez, X., Cacabelos, R., & Quack, G. (2002). Neuroprotection by memantine against neurodegeneration induced by beta-amyloid (1-40). Brain Research, 958, 210-221. (Pubitemid 35441230)
32. Morris, J. C., Storandt, M, Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., et al. (2001). Mild cognitive impairment represents early-stage Alzheimer disease. Archives of Neurology, 58, 397-405. (Pubitemid 32217456)
33. Muir, J. L. (1997). Acetylcholine, aging, and Alzheimer's disease. Pharmacology, Biochemistry and Behavior, 56, 687-696. (Pubitemid 27189754)
34. Mumenthaler, M S., Taylor, J. L., O'Hara, R., & Yesavage, J. A. (1998). Influence of nicotine on simulator flight performance in non-smokers. Psychopharmacology, 140, 38-41. (Pubitemid 28524305)
35. Mumenthaler, M S., Yesavage, J. A., Taylor, J. L., O'Hara, R., Friedman, L., Lee, H., et al. (2003). Psychoactive drugs and pilot performance: A comparison of nicotine, donepezil, and alcohol effects. Neuropsychopharmacology, 28, 1366-1373. (Pubitemid 41070908)
36. Nilsson, L., Nordberg, A., Hardy, J., Wester, P., & Winblad, B. (1986). Physostigmine restores 3H-acetylcholine efflux from Alzheimer brain slices to normal level. Journal of Neural Transmission, 67, 275-285. (Pubitemid 17184853)
37. O'Hara, R., Yesavage, J. A., Kreamer, H. C., Mauricio, M, Friedman, L. F., & Murphy, G. M, Jr. (1998). The ApoE E4 allele is associated with decline on delayed recall performance in community-dwelling elderly adults. Journal of the American Geriatrics Society, 46, 1493-1498. (Pubitemid 28551194)
38. Pearman, A., Friedman, L., Brooks, J. O., & Yesavage, J. A. (2000). Hearing impairment and serial word recall in older adults. Experimental and Aging Research, 26, 383-391.
39. Perry, E. K., Gibson, P. H., Blessed, G., Perry, R. H., & Tomlinson, B. E. (1977). Neurotransmitter enzyme abnormalities in senile dementia: Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. Journal of the Neurological Sciences, 34, 247-265. (Pubitemid 8188071)
40. Perry, E. K., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P. H., & Perry, R. H. (1978). Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. British Medical Journal, 2, 1457-1459. (Pubitemid 9061468)
41. Peskind, E. R., Pomara, N., Potkin, S. G., McDonald, S., Xie, Y., & Gergel, I. (2004, February). Memantine monotherapy is effective and safe for the treatment of mild to moderate Alzheimer's disease: A randomized controlled trial. Poster session presented at the American Association for Geriatric Psychiatry, Baltimore, MD.
42. Petersen, R. C. (1995). Normal aging, mild cognitive impairment, and early Alzheimer's disease. Neurologist, 1, 326-344.
43. Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256, 183-194. (Pubitemid 39222988)
44. Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., Kokmen, E. (1999). Mild cognitive impairment: Clinical characterization and outcome. Archives of Neurology, 56, 303-308. (Pubitemid 29120227)
45. Petersen, R. C., Thomas, R. G., Grundman, M, Bennett, D., Doody, R., Ferris, S., et al. (2005). Vitamin E and donepezil for the treatment of mild cognitive impairment. New England Journal of Medicine, 352, 2379-2388. (Pubitemid 40958434)
46. Prendergast, M A., Terry, A. V., Jr., Jackson, W. J., Marsh, K. C., Decker, M W., & Arneric, S. P. (1997). Improvement in accuracy of delayed recall in aged and non-aged, mature monkeys after intramuscular or transdermal administration of the CNS nicotinic receptor agonist ABT-418. Psychopharmacology (Berlin), 130, 276-284. (Pubitemid 27170361)
47. Randall, D. C., Viswanath, A., Bharania, P., Elsabagh, S. M, Hartley, D. E., Shneerson, J. M, et al. (2005). Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived? Journal of Clinical Psychopharmacology, 25, 175-179. (Pubitemid 40395097)
48. Rapp, S., Brenes, G., & Marsh, A. P. (2002). Memory enhancement training for older adults with mild cognitive impairment: A preliminary study. Aging & Mental Health, 6, 5-11. (Pubitemid 34146143)
49. Reisberg, B., Doody, R., Stoffler, A., Schmitt, F., Ferris, S., & Mobius, H. (2003). Memantine in moderate-to-severe Alzheimer's disease. New England Journal of Medicine, 348, 1333-1341. (Pubitemid 36384100)
50. Requena, C., Lopez-Ibor, M I., Maestu, F., Campo, P., Lopez-Ibor, J. J., & Ortiz, T. (2004). Effects of cholinergic drugs and cognitive training on dementia. Dementia and Geriatric Cognitive Disorders, 18, 50-54. (Pubitemid 38822738)
51. Robertson-Tschabo, E. A., Hausmann, C. P., & Arenberg, D. (1976). A classical mnemonic for older learners: A trip that works! Educational Gerontology, 1, 215-226.
52. Robinson, D., Friedman, L., Marcus, R., Tinklenberg, J., & Yesavage, J. (1994). Estrogen replacement therapy and memory in older women. Journal of the American Geriatrics Society, 42, 919-922. (Pubitemid 24280363)
53. Rogawski, M, & Wenk, G. (2003). The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. CNS Drug Review, 9, 275-308. (Pubitemid 37254706)
54. Rosenthal, M, & Bryant, S. (2004). Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia. Clinical Neuropharmacology, 27, 38-43. (Pubitemid 38280387)
55. Rylett, R. J., Ball, M J., & Colhoun, E. H. (1983). Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease. Brain Research, 289, 169-175. (Pubitemid 14222517)
56. Sahakian, B., Jones, G., Levy, R., Gray, J., & Warburton, D. (1989). The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. British Journal of Psychiatry, 154, 797-800. (Pubitemid 19172212)
57. Saykin, A. J., Wishart, H. A., Rabin, L. A., Flashman, L. A., McHugh, T. L., Mamourian, A. C., et al. (2004). Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain, 127, 1574-1583. (Pubitemid 38899410)
58. Sevy, S., Rosenthal, M H., Alvir, J., Meyer, S., Visweswaraiah, H., Gunduz-Bruce, H., et al. (2005). Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications. Journal of Clinical Psychiatry, 66, 839-843. (Pubitemid 41032824)
59. Sherwin, B. (2000). Mild cognitive impairment: Potential pharmacological treatment options. Journal of the American Geriatrics Society, 48, 431-441. (Pubitemid 30207770)
60. Spence, S. A., Green, R. D., Wilkinson, I. D., & Hunter, M D. (2005). Modafinil modulates anterior cingulate function in chronic schizophrenia. British Journal of Psychiatry, 187, 55-61. (Pubitemid 41002514)
61. Tariot, P., Farlow, M, Grossberg, G., Graham, S., McDonald, S., & Gergel, I. (2004). Memantine treatment in patients with moderate to severe Alzheimer's disease already receiving donepezil: A randomized controlled trial. Journal of the American Medical Association, 291, 317-324. (Pubitemid 38101604)
62. Taylor, J. L., O'Hara, R., Mumenthaler, M S., & Yesavage, J. A. (2000). Relationship of CogScreen-AE to flight simulator performance and pilot age. Aviation, Space, and Environmental Medicine, 71, 373-380. (Pubitemid 30170131)
63. Turner, D. C., Clark, L., Pomarol-Clotet, E., McKenna, P., Robbins, T. W., & Sahakian, B. J. (2004). Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology, 29, 1363-1373. (Pubitemid 38780659)
64. Turner, D. C., Robbins, T. W., Clark, L., Aron, A. R., Dowson, J., & Sahakian, B. J. (2003). Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology, 165, 260-269. (Pubitemid 36197601)
65. Wechsler, D. (1987). Wechsler Memory Scale-Revised. San Antonio, TX: Psychological Corporation.
66. White, P., Hiley, C. R., Goodhardt, M J., Carrasco, L. H., Keet, J. P., & Williams, I. E. (1977) Neocortical cholinergic neurons in elderly people. Lancet, 1, 668-671.
67. Whitehouse, P. J., Juengst, E. T., Mehlman, M, & Murray, T. (1997). Enhancing cognition in the intellectually intact: Possibilities and pitfalls. Hastings Center Report, 3, 14-22.
68. Whitehouse, P. J., Price, D. L., Struble, R. G., Clark, A. W., & Coyle, J. T. (1982). Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science, 215, 1237-1239. (Pubitemid 12106486)
69. Yerkes, R. M, & Dodson, J. D. (1908). The relation of strength of stimulus to rapidity of habit formation. Journal of Comparative Neurology and Psychology, 18, 459-482.
70. Yesavage, J. A. (1985). Non-pharmacologic treatments for memory losses with normal aging. American Journal of Psychiatry, 142, 600-605. (Pubitemid 15034630)
71. Yesavage, J. A. (1989). Techniques for cognitive training of memory in age-associated memory impairment. Archives of Gerontology and Geriatrics, Suppl. 1, 185-190. (Pubitemid 19106371)
72. Yesavage, J. A. (1990). Attention versus retention and geriatric psychopharmacology. In M Bergener & S. I. Finkel (Eds.), Clinical and scientific psychogeriatrics: The interface of psychiatry and neurology (Vol. 2, pp. 45-60). New York: Springer.
73. Yesavage, J. A., Brooks, J. O., Lapp, D., O'Hara, R., Mancilla-Koch, C, & Friedman, L. (1999). Training to improve memory performance in Hispanic community-dwelling older adults. Clinical Gerontologist, 21, 61-65. (Pubitemid 30108627)
74. Yesavage, J. A., Mumenthaler, M, Taylor, J. L., Friedman, L. F., O'Hara, R., Sheikh, J., et al. (2002). Donepezil and flight simulator performance: Effects on retention of complex skills. Neurology, 59, 123-125. (Pubitemid 34742807)
75. Yesavage, J. A., O'Hara, R., Kraemer, H. C., Noda, A., Taylor, J. L., Ferris, S., et al. (2002). Modeling the prevalence and incidence of Alzheimer's disease and mild cognitive impairment. Journal of Psychiatric Research, 36, 281-286. (Pubitemid 34764052)
76. Yesavage, J. A., & Rose, T. L. (1984a). The effects of a face-name mnemonic in young, middle-aged, and elderly adults. Experimental Aging Research, 10, 55-57. (Pubitemid 14117554)
77. Yesavage, J. A., & Rose, T. L. (1984b). Semantic elaboration and the method of loci: A new trip for older learners. Experimental Aging Research, 10, 155-159. (Pubitemid 15198414)
78. Yesavage, J. A., Sheikh, J. I., Friedman, L., & Tank, E. (1990). Learning mnemonics: Roles of aging and subtle cognitive impairment. Psychology and Aging, 5, 133-137.